Bhatt Elizabeth
President and COO
Sale 10b5-1
- Shares
- 2,906
- Price
- $37.61
- Value
- $109,307
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•46 filings
SEPN
Septerna, Inc.
Net sales of $72.3M over the last 3 months
13 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$72,343,000
0 buyers · 13 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$76,204,534
14 distinct insiders
Highlighted alerts
3
26 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get SEPN insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
SEPN overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
29
Voluntary view
P/S trades after deterministic checks
71
Administrative noise
Stored, never alerted
68
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 4,000
- Price
- $6.81
- Footnotes
- 4
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on October 20, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.24 to $37.23. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.31 to $38.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 28, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.
Raspberry interpretation
Informational — no alert
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Bhatt Elizabeth
President and COO
Sale 10b5-1
- Shares
- 1,094
- Price
- $36.87
- Value
- $40,337
Long Daniel D.
SVP, Drug Discovery
Sale 10b5-1
- Shares
- 3,333
- Price
- $37.83
- Value
- $126,078
RA CAPITAL MANAGEMENT, L.P.
Director
SaleAlert
- Shares
- 746,500
- Price
- $42.50
- Value
- $31,726,250
RA CAPITAL MANAGEMENT, L.P.
Director
SaleAlert
- Shares
- 746,500
- Price
- $42.50
- Value
- $31,726,250
Third Rock Ventures V, L.P.
10% owner
Sale 10b5-1
- Shares
- 141
- Price
- $51.08
- Value
- $7,202
Third Rock Ventures V, L.P.
10% owner
Sale 10b5-1
- Shares
- 147,059
- Price
- $50.27
- Value
- $7,392,656
Bhatt Elizabeth
President and COO
Sale 10b5-1
- Shares
- 25,000
- Price
- $44.00
- Value
- $1,100,000
Long Daniel D.
SVP, Drug Discovery
Sale 10b5-1
- Shares
- 2,334
- Price
- $34.68
- Value
- $80,944
Long Daniel D.
SVP, Drug Discovery
Sale 10b5-1
- Shares
- 1,000
- Price
- $33.98
- Value
- $33,976
Bhatt Elizabeth
President and COO
Sale 10b5-1
- Shares
- 4,000
- Price
- $33.99
- Value
- $135,974
Long Daniel D.
SVP, Drug Discovery
Sale 10b5-1
- Shares
- 1,233
- Price
- $34.81
- Value
- $42,926
Long Daniel D.
SVP, Drug Discovery
Sale 10b5-1
- Shares
- 2,100
- Price
- $34.10
- Value
- $71,602
Shaikhly Samira
Chief People Officer
Sale 10b5-1
- Shares
- 2,178
- Price
- $35.18
- Value
- $76,622
Long Daniel D.
SVP, Drug Discovery
Sale 10b5-1
- Shares
- 7,000
- Price
- $35.97
- Value
- $251,781
Long Daniel D.
SVP, Drug Discovery
Sale 10b5-1
- Shares
- 8,000
- Price
- $35.10
- Value
- $280,801
Shaikhly Samira
Chief People Officer
Sale 10b5-1
- Shares
- 6,250
- Price
- $35.08
- Value
- $219,224
Shaikhly Samira
Chief People Officer
Sale 10b5-1
- Shares
- 2,889
- Price
- $29.66
- Value
- $85,696
Shaikhly Samira
Chief People Officer
Sale 10b5-1
- Shares
- 1,346
- Price
- $28.79
- Value
- $38,755
Shaikhly Samira
Chief People Officer
Sale 10b5-1
- Shares
- 1,700
- Price
- $27.78
- Value
- $47,231
Shaikhly Samira
Chief People Officer
Sale 10b5-1
- Shares
- 11,798
- Price
- $30.06
- Value
- $354,656
Bhatt Elizabeth
President and COO
Sale 10b5-1
- Shares
- 326
- Price
- $25.86
- Value
- $8,431
Bhatt Elizabeth
President and COO
Sale 10b5-1
- Shares
- 1,101
- Price
- $25.24
- Value
- $27,789
Bhatt Elizabeth
President and COO
Sale 10b5-1
- Shares
- 2,573
- Price
- $23.76
- Value
- $61,124
Shaikhly Samira
Chief People Officer
Sale 10b5-1
- Shares
- 66,363
- Price
- $28.14
- Value
- $1,867,342
Shaikhly Samira
Chief People Officer
Sale 10b5-1
- Shares
- 4,090
- Price
- $27.51
- Value
- $112,496
Bhatt Elizabeth
President and COO
Sale 10b5-1
- Shares
- 1,800
- Price
- $29.58
- Value
- $53,250
Bhatt Elizabeth
President and COO
Sale 10b5-1
- Shares
- 2,200
- Price
- $28.46
- Value
- $62,611
Long Daniel D.
SVP, Drug Discovery
SaleAlert
- Shares
- 3,501
- Price
- $18.06
- Value
- $63,223
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Bhatt Elizabeth President and COO | Sale | 2,906 | $37.61 | $109,307 | |
| Oct 15, 2026 | Bhatt Elizabeth President and COO | Sale | 1,094 | $36.87 | $40,337 | |
| Sep 01, 2026 | Long Daniel D. SVP, Drug Discovery | Sale | 3,333 | $37.83 | $126,078 | |
| Aug 12, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 746,500 | $42.50 | $31,726,250 | |
| Aug 12, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 746,500 | $42.50 | $31,726,250 | |
| Aug 12, 2026 | Third Rock Ventures V, L.P. 10% owner | Sale | 141 | $51.08 | $7,202 | |
| Aug 12, 2026 | Third Rock Ventures V, L.P. 10% owner | Sale | 147,059 | $50.27 | $7,392,656 | |
| Aug 11, 2026 | Bhatt Elizabeth President and COO | Sale | 25,000 | $44.00 | $1,100,000 | |
| Aug 03, 2026 | Long Daniel D. SVP, Drug Discovery | Sale | 2,334 | $34.68 | $80,944 | |
| Aug 03, 2026 | Long Daniel D. SVP, Drug Discovery | Sale | 1,000 | $33.98 | $33,976 | |
| Jul 15, 2026 | Bhatt Elizabeth President and COO | Sale | 4,000 | $33.99 | $135,974 | |
| Jul 01, 2026 | Long Daniel D. SVP, Drug Discovery | Sale | 1,233 | $34.81 | $42,926 | |
| Jul 01, 2026 | Long Daniel D. SVP, Drug Discovery | Sale | 2,100 | $34.10 | $71,602 | |
| Jun 29, 2026 | Shaikhly Samira Chief People Officer | Sale | 2,178 | $35.18 | $76,622 | |
| Jun 22, 2026 | Long Daniel D. SVP, Drug Discovery | Sale | 7,000 | $35.97 | $251,781 | |
| Jun 22, 2026 | Long Daniel D. SVP, Drug Discovery | Sale | 8,000 | $35.10 | $280,801 | |
| Jun 12, 2026 | Shaikhly Samira Chief People Officer | Sale | 6,250 | $35.08 | $219,224 | |
| Jun 01, 2026 | Shaikhly Samira Chief People Officer | Sale | 2,889 | $29.66 | $85,696 | |
| Jun 01, 2026 | Shaikhly Samira Chief People Officer | Sale | 1,346 | $28.79 | $38,755 | |
| Jun 01, 2026 | Shaikhly Samira Chief People Officer | Sale | 1,700 | $27.78 | $47,231 | |
| May 26, 2026 | Shaikhly Samira Chief People Officer | Sale | 11,798 | $30.06 | $354,656 | |
| Apr 15, 2026 | Bhatt Elizabeth President and COO | Sale | 326 | $25.86 | $8,431 | |
| Apr 15, 2026 | Bhatt Elizabeth President and COO | Sale | 1,101 | $25.24 | $27,789 | |
| Apr 15, 2026 | Bhatt Elizabeth President and COO | Sale | 2,573 | $23.76 | $61,124 | |
| Mar 02, 2026 | Shaikhly Samira Chief People Officer | Sale | 66,363 | $28.14 | $1,867,342 | |
| Mar 02, 2026 | Shaikhly Samira Chief People Officer | Sale | 4,090 | $27.51 | $112,496 | |
| Feb 18, 2026 | Bhatt Elizabeth President and COO | Sale | 1,800 | $29.58 | $53,250 | |
| Feb 18, 2026 | Bhatt Elizabeth President and COO | Sale | 2,200 | $28.46 | $62,611 | |
| Nov 10, 2025 | Long Daniel D. SVP, Drug Discovery | Sale | 3,501 | $18.06 | $63,223 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.